KBC Group NV Acquires 67,250 Shares of DaVita Inc. (NYSE:DVA)

KBC Group NV boosted its holdings in shares of DaVita Inc. (NYSE:DVA) by 27.3% in the 3rd quarter, Holdings Channel.com reports. The firm owned 313,519 shares of the company’s stock after purchasing an additional 67,250 shares during the quarter. KBC Group NV’s holdings in DaVita were worth $51,395,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DVA. Texas Permanent School Fund Corp increased its position in DaVita by 5.6% during the first quarter. Texas Permanent School Fund Corp now owns 11,133 shares of the company’s stock worth $1,537,000 after acquiring an additional 588 shares during the period. Empowered Funds LLC acquired a new position in shares of DaVita during the first quarter valued at about $404,000. Sei Investments Co. lifted its stake in shares of DaVita by 21.3% in the first quarter. Sei Investments Co. now owns 41,952 shares of the company’s stock valued at $5,790,000 after buying an additional 7,371 shares during the period. State Board of Administration of Florida Retirement System grew its position in DaVita by 8.3% during the first quarter. State Board of Administration of Florida Retirement System now owns 73,574 shares of the company’s stock worth $10,157,000 after buying an additional 5,625 shares in the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in DaVita by 13.5% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 61,570 shares of the company’s stock valued at $8,500,000 after acquiring an additional 7,300 shares during the period. Institutional investors and hedge funds own 90.12% of the company’s stock.

Wall Street Analyst Weigh In

DVA has been the subject of a number of research reports. TD Cowen raised their price objective on DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a research report on Wednesday, July 24th. UBS Group raised their target price on DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Truist Financial boosted their price target on shares of DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a report on Monday, October 7th. Barclays raised their price objective on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a report on Thursday, October 31st. Finally, Bank of America upped their target price on shares of DaVita from $139.00 to $145.00 and gave the company an “underperform” rating in a research note on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $161.80.

Insider Activity at DaVita

In other DaVita news, CFO Joel Ackerman sold 64,029 shares of the stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $155.06, for a total value of $9,928,336.74. Following the completion of the sale, the chief financial officer now directly owns 111,481 shares in the company, valued at $17,286,243.86. This represents a 36.48 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Javier Rodriguez sold 32,176 shares of DaVita stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $155.93, for a total transaction of $5,017,203.68. Following the completion of the transaction, the chief executive officer now directly owns 905,659 shares in the company, valued at approximately $141,219,407.87. The trade was a 3.43 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 156,086 shares of company stock worth $24,807,161 in the last ninety days. Company insiders own 2.00% of the company’s stock.

DaVita Trading Down 1.8 %

Shares of NYSE DVA opened at $154.38 on Friday. The company’s 50 day simple moving average is $157.57 and its 200 day simple moving average is $147.35. The firm has a market capitalization of $12.66 billion, a P/E ratio of 16.65, a P/E/G ratio of 0.89 and a beta of 0.89. DaVita Inc. has a fifty-two week low of $91.87 and a fifty-two week high of $168.50. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33.

DaVita (NYSE:DVA) last released its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a net margin of 6.53% and a return on equity of 88.18%. The company had revenue of $3.26 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the prior year, the company posted $2.85 EPS. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. On average, analysts predict that DaVita Inc. will post 9.71 EPS for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.